Overview

A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

Status:
Completed
Trial end date:
2009-05-14
Target enrollment:
Participant gender:
Summary
This study will be conducted in healthy volunteers to investigate the effect of single dose GSK561679 on the changes of brain activation, as it compares to an active comparator, lorazepam.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Lorazepam